Semmelweis Publications
  • Main page

    • Dóra, Dávid Semmelweis University affiliated publications (2020-2025)

    Year:
    Order by:
    Authorship:
    Number of publications: 26
    1.
    Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
    Dora, D;Ligeti, B;Kovacs, T;Revisnyei, P;Galffy, G;Dulka, E;Krizsán, D;Kalcsevszki, R;Megyesfalvi, Z;Dome, B;Weiss, GJ;Lohinai, Z
    Q1
    ONCOIMMUNOLOGY
    2023.
    DOI:10.1080/2162402X.2023.2204746 (Copy DOI)
    2.
    Evidence of a Myenteric Plexus Barrier and Its Macrophage-Dependent Degradation During Murine Colitis: Implications in Enteric Neuroinflammation
    Dora, D;Ferenczi, S;Stavely, R;Toth, VE;Varga, ZV;Kovacs, T;Bodi, I;Hotta, R;Kovacs, KJ;Goldstein, AM;Nagy, N
    D1
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
    2021.
    DOI:10.1016/j.jcmgh.2021.07.003 (Copy DOI)
    3.
    Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
    Dora, D;Rivard, C;Yu, H;Bunn, P;Suda, K;Ren, SX;Pickard, SL;Laszlo, V;Harko, T;Megyesfalvi, Z;Moldvay, J;Hirsch, FR;Dome, B;Lohinai, Z
    D1
    MOLECULAR ONCOLOGY
    2020.
    DOI:10.1002/1878-0261.12741 (Copy DOI)
    4.
    Loss of STING expression is prognostic in non-small cell lung cancer
    Lohinai, Z;Dora, D;Caldwell, C;Rivard, CJ;Suda, K;Yu, H;Rivalland, G;Ellison, K;Rozeboom, L;Dziadziuszko, R;Mitchell, P;John, T;Millan, IS;Ren, SX;Hirsch, FR
    Q1
    JOURNAL OF SURGICAL ONCOLOGY
    2022.
    DOI:10.1002/jso.26804 (Copy DOI)
    5.
    Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer
    Dora, D;Rivard, C;Yu, H;Pickard, SL;Laszlo, V;Harko, T;Megyesfalvi, Z;Dinya, E;Gerdan, C;Szegvari, G;Hirsch, FR;Dome, B;Lohinai, Z
    Q1
    BIOLOGY-BASEL
    2021.
    DOI:10.3390/biology10060502 (Copy DOI)
    6.
    Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer
    Dora, D;Rivard, C;Yu, H;Pickard, SL;Laszlo, V;Harko, T;Megyesfalvi, Z;Gerdan, C;Dinya, E;Hoetzenecker, K;Hirsch, FR;Lohinai, Z;Dome, B
    D1
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    2023.
    DOI:10.1007/s00262-022-03270-w (Copy DOI)
    7.
    Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
    Blaj, S;Dora, D;Lohinai, Z;Herold, Z;Szasz, AM;Herzberg, J;Kodacsi, R;Baransi, S;Schlitt, HJ;Hornung, M;Werner, JM;Slowik, P;Acs, M;Piso, P
    Q1
    CANCERS
    2023.
    DOI:10.3390/cancers15041326 (Copy DOI)
    8.
    Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
    Dora, D;Bokhari, SMZ;Aloss, K;Takacs, P;Desnoix, JZ;Szklenárik, G;Hurley, PD;Lohinai, Z
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms24032769 (Copy DOI)
    9.
    Efficient treatment of a preclinical inflammatory bowel disease model with engineered bacteria
    Ferenczi, S;Solymosi, N;Horváth, I;Szeocs, N;Grózer, Z;Kuti, D;Juhász, B;Winkler, Z;Pankotai, T;Sükösd, F;Stágel, A;Paholcsek, M;Dóra, D;Nagy, N;Kovács, KJ;Zanoni, I;Szallasi, Z
    Q1
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT
    2021.
    DOI:10.1016/j.omtm.2020.11.010 (Copy DOI)
    10.
    BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
    Dora, D;Vörös, I;Varga, ZV;Takacs, P;Teglasi, V;Moldvay, J;Lohinai, Z
    Q1
    TRANSLATIONAL LUNG CANCER RESEARCH
    2023.
    DOI:10.21037/tlcr-22-449 (Copy DOI)
    11.
    Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
    Dora, D;Weiss, GJ;Megyesfalvi, Z;Gállfy, G;Dulka, E;Kerpel-Fronius, A;Berta, J;Moldvay, J;Dome, B;Lohinai, Z
    Q1
    CANCERS
    2023.
    DOI:10.3390/cancers15205091 (Copy DOI)
    12.
    Depletion of muscularis macrophages ameliorates inflammation-driven dysmotility in murine colitis model
    Ferenczi, S;Mogor, F;Takacs, P;Kovacs, T;Toth, VE;Varga, ZV;Kovács, K;Lohinai, Z;Vass, KC;Nagy, N;Dora, D
    D1
    SCIENTIFIC REPORTS
    2023.
    DOI:10.1038/s41598-023-50059-7 (Copy DOI)
    13.
    Essential Role of BMP4 Signaling in the Avian Ceca in Colorectal Enteric Nervous System Development
    Kovacs, T;Halasy, V;Petho, C;Szocs, E;Soos, A;Dora, D;de Santa Barbara, P;Faure, S;Stavely, R;Goldstein, AM;Nagy, N
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms242115664 (Copy DOI)
    14.
    Effective Reversal of Macrophage Polarization by Inhibitory Combinations Predicted by a Boolean Protein-Protein Interaction Model
    Szegvari, G;Dora, D;Lohinai, Z
    Q1
    BIOLOGY-BASEL
    2023.
    DOI:10.3390/biology12030376 (Copy DOI)
    15.
    TALPID3/KIAA0586 Regulates Multiple Aspects of Neuromuscular Patterning During Gastrointestinal Development in Animal Models and Human
    Delalande, JM;Nagy, N;McCann, CJ;Natarajan, D;Cooper, JE;Carreno, G;Dora, D;Campbell, A;Laurent, N;Kemos, P;Thomas, S;Alby, C;Attie-Bitach, T;Lyonnet, S;Logan, MP;Goldstein, AM;Davey, MG;Hofstra, RMW;Thapar, N;Burns, AJ
    Q1
    FRONTIERS IN MOLECULAR NEUROSCIENCE
    2021.
    DOI:10.3389/fnmol.2021.757646 (Copy DOI)
    16.
    The Enteric Nervous System and the Microenvironment of the Gut: The Translational Aspects of the Microbiome-Gut-Brain Axis
    Mogor, F;Kovacs, T;Lohinai, Z;Dora, D
    Q2
    APPLIED SCIENCES-BASEL
    2021.
    DOI:10.3390/app112412000 (Copy DOI)
    17.
    EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers
    Dora, D;Dora, T;Szegvari, G;Gerdán, C;Lohinai, Z
    Q1
    BIODATA MINING
    2022.
    DOI:10.1186/s13040-022-00307-9 (Copy DOI)
    18.
    The role of intestinal macrophages and the enteric nervous system in gut neuroimmunology Basic science and clinical implications
    Dóra, D;Kovács, T;Nagy, N
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31685 (Copy DOI)
    19.
    Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review
    Szklenarik, G;Kiraly, P;Szegvari, G;Dora, D;Lohinai, Z
    Q1
    FRONTIERS IN MEDICINE
    2024.
    DOI:10.3389/fmed.2024.1488377 (Copy DOI)
    20.
    From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy
    Dora, D;Szocs, E;Soós, A;Halasy, V;Somodi, C;Mihucz, A;Rostás, M;Mógor, F;Lohinai, Z;Nagy, N
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1434804 (Copy DOI)
    21.
    Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients
    Dora, D;Revisnyei, P;Mihucz, A;Kiraly, P;Szklenarik, G;Dulka, E;Galffy, G;Lohinai, Z
    Q1
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
    2024.
    DOI:10.3389/fcimb.2024.1381170 (Copy DOI)
    22.
    Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer
    Dora, D;Kiraly, P;Somodi, C;Ligeti, B;Dulka, E;Galffy, G;Lohinai, Z
    D1
    JOURNAL OF TRANSLATIONAL MEDICINE
    2024.
    DOI:10.1186/s12967-024-05835-y (Copy DOI)
    23.
    Resolving Resident Colonic Muscularis Macrophage Diversity and Plasticity During Colitis
    Ohishi, K;Dora, D;Han, CY;Guyer, RA;Ohkura, T;Kazimierczyk, S;Picard, N;Leavitt, AR;Ott, LC;Rahman, AA;Mueller, JL;Shpigel, NY;Jain, N;Nagy, N;Hotta, R;Goldstein, AM;Stavely, R
    Q1
    INFLAMMATORY BOWEL DISEASES
    2025.
    DOI:10.1093/ibd/izae155 (Copy DOI)
    24.
    Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer
    Dora, D;Megyesfalvi, Z;Vörös, I;Paál, A;Takacs, P;Dobos, D;Lorincz, B;Bokhari, SMZ;Aloss, K;Pallag, G;Rivard, C;Yu, H;Hirsch, FR;Görbe, A;Varga, ZV;Lohinai, Z;Dome, B
    D1
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    2025.
    DOI:10.1007/s00262-025-04006-2 (Copy DOI)
    25.
    Roles of Annexin A1 Expression in Small Cell Lung Cancer
    Paál, Ágnes; Dora, David; Takács, Ákos; Rivard, Christopher; Pickard, Shivaun Lueke; Hirsch, Fred R.; Roskó, Brigitta; Kiraly, Peter; Ferdinandy, Péter; Varga, Zoltán V.; Lohinai, Zoltan; Görbe, Anikó;
    Q1
    CANCERS 2072-6694
    2025.
    DOI:10.3390/cancers17091407 (Copy DOI)
    26.
    Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients
    Dora, David; Revisnyei, Peter; Pasic, Alija; Galffy, Gabriella; Dulka, Edit; Mihucz, Anna; Roskó, Brigitta; Szincsak, Sara; Iliuk, Anton; Weiss, Glen J.; Lohinai, Zoltan;
    Q1
    FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224
    2025.
    DOI:10.3389/fimmu.2025.1543817 (Copy DOI)

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_5
    Department data last refreshed at: 28.04.2025
    Author data last refreshed at: 28.04.2025
    (c) Semmelweis University - Central Library